Treatment of PTEN-deficient CRC cells with LY294002 (PI3K/mTOR inhibitor) and rapamycin (mTOR inhibitor) inhibited phosphorylation of AKT and mTOR, while Stattic did not. The gene discussed is MTOR; the disease is colorectal carcinoma.